APA

Bertherat J., Chanson P., Dewailly D., Enjalbert A., Jaquet P., Kordon C., Peillon F., Timsit J. & Epelbaum J. (19930812). Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog. : Hormone research.

Chicago

Bertherat J, Chanson P, Dewailly D, Enjalbert A, Jaquet P, Kordon C, Peillon F, Timsit J and Epelbaum J. 19930812. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog. : Hormone research.

Harvard

Bertherat J., Chanson P., Dewailly D., Enjalbert A., Jaquet P., Kordon C., Peillon F., Timsit J. and Epelbaum J. (19930812). Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog. : Hormone research.

MLA

Bertherat J, Chanson P, Dewailly D, Enjalbert A, Jaquet P, Kordon C, Peillon F, Timsit J and Epelbaum J. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog. : Hormone research. 19930812.